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Abstract
Animal models suggest that interactions between the hippocampus and ventral tegmental area (VTA) underlie
the onset and etiology of psychosis. While a large body of research has separately characterized alterations in
hippocampal and VTA function in psychosis, alterations across the VTA and hippocampus have not been
characterized in first-episode psychosis (FEP). As the phase of psychosis most proximal to conversion, studies
specifically focused on FEP are valuable to psychosis research. Here, we characterize alterations in VTA-hip-
pocampal interactions across male and female human participants experiencing their first episode of psycho-
sis using resting state functional magnetic resonance imaging (rsfMRI). In comparison to age and sex matched
healthy controls (HCs), FEP individuals had significantly greater VTA-hippocampal functional coupling but sig-
nificantly less VTA-striatal functional coupling. Further, increased VTA-hippocampal functional coupling in FEP
correlated with individual differences in psychosis-related symptoms. Together, these findings demonstrate al-
terations in mesolimbic-hippocampal circuits in FEP and extend prominent animal models of psychosis.
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Significance Statement
We characterized differences in functional coupling between the VTA and hippocampus in FEP. We found
enhanced functional coupling between the VTA and right hippocampus in FEP, which correlated with indi-
vidual differences in psychosis symptoms. We broaden a growing literature characterizing mesolimbic-hip-
pocampal interactions, showing a prominent role for this circuit in psychosis. Further, our findings connect
well with animal models of psychosis which detail alterations in this circuit as a risk factor for developing
psychosis. These findings support a model of increased functional interactions between the hippocampus
and VTA with etiology of psychosis and may predict individual differences in psychosis-related symptoms.
Introduction
Psychosis is associated with alterations in the mesolimbic
dopamine system, which has been linked with psychosis
onset and related positive symptoms (i.e., delusions, para-
noia). Rodent studies modeling mesolimbic deficits in psy-
chosis show that hyperactivity in baseline hippocampal
function results in an upregulation of tonic dopamine signal-
ing in the ventral tegmental area (VTA; Lisman and Grace,
2005). In the methylazoxymethanol acetate (MAM) model, a
rodent model of psychosis, reduced GABA-ergic signaling
in the hippocampus leads to hippocampal hyperactivity,
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leading to an increased tonic signaling within the VTA
(Lodge and Grace, 2011). A growing body of research
has shown that mesolimbic-hippocampal interactions
in healthy human adults are homologous to animal
models (Miendlarzewska et al., 2016; Murty and Alison
Adcock, 2017), such that there is functional coupling
between the VTA and hippocampus during novelty and
reward processing (Miendlarzewska et al., 2016; Murty
and Alison Adcock, 2017) and during resting state
(Kahn and Shohamy, 2013; Gregory et al., 2020). In the
current study, we used resting state functional mag-
netic resonance imaging (rsfMRI) to compare functional
coupling of the mesolimbic system and hippocampus
between cohorts of individuals in their first-episode of
psychosis (FEP) and healthy controls (HCs).
Current research in FEP, described as the first time an
individual receive a diagnosis of psychosis/are within their
first episode of psychosis, has been sparce in the psycho-
sis literature (Bommersbach et al., 2021). However, char-
acterizing FEP individuals is important to understand the
onset and progression of this disorder. The clinical ex-
pression of psychosis varies between individuals at differ-
ent stages of disorder progression, thus understanding
mesolimbic dysfunction in FEP provides an opportunity to
detail markers of psychosis closer to the onset of the dis-
order in the absence of confounds of prolonged medica-
tion and chronic illness (Breitborde et al., 2015).
Previous research has shown disruptions in task-
evoked VTA activation in individuals with psychosis
(Ermakova et al., 2018; McCutcheon et al., 2019).
Increased dopaminergic signaling in prodromal popu-
lations reflects negative symptoms and predicts
conversion to psychosis (Howes et al., 2009; Abi-
Dargham, 2017). In parallel, individuals with psychosis
reliably show reductions in hippocampal structural in-
tegrity (van Erp et al., 2016; Vargas et al., 2018), im-
pairments in behavioral indices of hippocampal
function (Saykin, 1991; Heinrichs and Zakzanis, 1998;
Lee and Park, 2005), increases in hippocampal gluta-
mate levels measured by spectroscopy (Bossong et
al., 2019; Bustillo et al., 2019), and increases in cere-
bral blood flow in hippocampus (Allen et al., 2018).
Last, hippocampal and VTA deficits are present across
the phases of psychotic illness and in those at high risk
for developing the disorder (Kraguljac et al., 2013;
Baglivo et al., 2018; Modinos et al., 2018).
Despite animal models of psychosis predicting VTA
modulation of medial temporal lobe (MTL) through
alterations which impact mesolimbic-hippocampal inter-
actions (Lodge and Grace, 2008; Gomes and Grace,
2018), VTA and hippocampal activation are often charac-
terized separately in patient populations. Recently, re-
search has begun to characterize interactions across the
VTA and hippocampus in psychosis-related populations
(for review, see Modinos et al., 2015). A study found that,
during the processing of novel environments, individuals at
clinical high risk (CHR) for developing psychosis exhibited
attenuated functional coupling between the VTA and hip-
pocampus; moreover, these alterations were greater in in-
dividuals that converted to having psychosis versus not
(Modinos et al., 2020). Further, hippocampus-VTA connec-
tivity was altered in a sample of individuals with chronic
schizophrenia, finding a correlation with positive symptoms
during resting state but importantly Nakamura and col-
leagues did not find differences across individuals with
schizophrenia and controls as well as those with other neu-
ropsychiatric disorders (Nakamura et al., 2020). Overall,
these studies highlight a critical role for hippocampus-VTA
circuits in psychosis, which has been found within animal
models but open questions remain regarding the charac-
terization of this circuit in human research on FEP.
In the current study, we assessed group differences in
rsfMRI functional coupling in FEP versus HC (FEP: N=46;
HC: N=32), with purpose to characterize how deficits in
mesolimbic-hippocampal interactions are related to psy-
chosis symptoms. Here, we classify FEP as individuals
who are in a first episode of psychosis which is proximal
to the onset of the disorder (Manivannan et al., 2019),
which can extend over prolonged periods of time if the
episode is continuous (i.e., months). Our hypothesis was
that the FEP group would display greater functional cou-
pling between the VTA and hippocampus compared with
HC. In line with animal models, we also hypothesize that
these rsfMRI functional coupling differences would be
specific to the hippocampus and not appear in other re-
gions of the MTL [i.e., perirhinal cortex (PRC)] or other tar-
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using medical, neurologic, and psychiatric assessments.
The final sample (from a total of 80 participants, two re-
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Exclusion criteria for all participants included: signifi-
cant neurologic disorder, head injury, or medical illness
affecting the central nervous system function, IQ lower
than 75 (determined using the Wechsler Abbreviated
Scale of Intelligence), DSM-IV substance dependence or
substance abuse disorder within the prior six months, or
any contraindications for use of MRI. Individuals were in-
cluded in the FEP group if they were within their first epi-
sode of psychotic symptoms and were antipsychotic-
naive or prescribed antipsychotic treatment across their
lifetime for less than two months. Diagnoses were deter-
mined using all available clinical information and data
gathered from a Structured Clinical Interview for DSM-IV
(SCID) conducted by a trained Master’s-level or PhD-level
clinician. Information on SCID in use of FEP diagnosis fol-
lowed methods described previously (Manivannan et al.,
2019). At least three senior clinical researchers would
then arrive at a consensus regarding diagnosis at a diag-
nostic conference in which all available clinical data were
reviewed. Illness duration for each patient was also deter-
mined in the consensus conference after a review of his-
torical information about psychosis onset. Individuals
were only included in the HC group if they had no lifetime
history of a major psychiatric disorder or antipsychotic
treatment, as well as no first-degree family member with a
history of a psychotic disorder.
Data acquisition
All participants completed a rsfMRI scan as part of a
larger protocol that included structural imaging, diffusion
imaging, and task-based fMRI. For the current study, only
rsfMRI data were analyzed, which was collected ;35min
into the scan session after structural and task fMRI
(Jalbrzikowski et al., 2018). MRI data were collected on a
3.0 T Siemens Tim Trio at the University of Pittsburgh
Medical Center Magnetic Resonance Center using a
32-channel phase array head coil. For fMRI acquisition,
a single-shot echo-planar imaging sequence sensitive
to BOLD contrast (T2*) was collected (TR = 1000 s;
TE = 30ms; flip angle = 55°; voxel size: 2.3-mm isotropic
voxels AC/PC aligned, 60 contiguous axial slices; 300
acquisitions). We also collected a high-resolution ana-
tomic image (MPRAGE, voxel size: 1.0-mm isotropic
voxels). We preprocessed rsfMRI scans using an estab-
lished pipeline (Hallquist et al., 2013). Briefly, the pre-
processing steps were: (1) simultaneous 4D slice-timing
and head motion correction, (2) wavelet de-spiking, (3)
nonlinear warping to MNI space, (4) spatial smoothing with a
5-mmGaussian kernel, (5) and simultaneous bandpass filter-
ing (0.009–0.08Hz) and nuisance regression. For nuisance
regression, we also regressed out effects of head motion
(6° of translation/rotation and their first derivative) and non-
gray matter signal (i.e., white matter and cerebrospinal fluid,
and their first derivative). Given that head motion is critical
for between group comparisons, we additionally calculated
two quality control measures of motion: volume-to-volume
framewise displacement (FD) and the RMS derivative of fMRI
time-series (DVARS). For each participant, we identified vol-
umes that had an FD. 0.3 mm and/or DVARS. 20 (com-
puted after wavelet de-spiking). These “flagged” volumes
were excluded for all pair-wise correlations (detailed below).
Resting-state scans consisted of 360 acquisitions with a TR
of 1260ms/scan, yielding a total scan duration of 7.5min
during which participants kept their eyes open and focused
on a fixation cross for the duration of the scan.
Analysis
For each individual participant, time-series were ex-
tracted from our seven regions of interest (ROIs). All ROIs
were defined from probabilistic atlases and thresholded
at 75%. The hippocampus and NAcc were defined from
the Harvard-Oxford Subcortical Atlas (https://neurovault.
org/collections/262/). We limited our analysis to the ante-
rior third of the long-axis of the hippocampus, given the
established role of this region in psychosis (Schobel et al.,
2009; McHugo et al., 2019) as well as in mesolimbic-hip-
pocampal interactions (Murty et al., 2017). The VTA was
defined from a probabilistic atlas defined in a prior resting
state study (Murty et al., 2014), and the PRC was defined
from a probabilistic atlas defined in an emotional memory
study (Ritchey et al., 2019). Figure 1 displays the ROIs
used for analyses. Next, we extracted time series for each
ROI and generated pair-wise correlations removing flagged
volumes using the corr function in MATLAB. All correlation R
values were converted to Z-scores using a Fischer trans-
form. All flagged time points were removed from time-series
analysis. Our protocol implements the removal of partici-
pants with more than a quarter of time points flagged for ex-
clusion, but no participants met this threshold. Then, group-
level analyses were performed using the t.test function in R,
with pair-wise correlation scores of functional coupling be-
tween ROI seed (the VTA) to each ROI target (i.e., right ante-
rior hippocampus) as the dependent variable and cohort
(FEP or HC) as the independent variable. All significant anal-
yses were confirmed to remain significant when including
age and sex as additional regressors using the lm function
in R. These analyses were corrected for multiple compari-
sons using Bonferroni correction. Finally, within the FEP
group, we ran simple regressions between functional cou-
pling scores for the VTA-hippocampus with symptom
scores on the Brief Psychiatric Rating Scale. We then veri-
fied in post hoc regression analyses using the partialcorr
function in MATLAB with age, sex, and antipsychotic status
covariates. Finally, we also included functional coupling be-
tween the VTA-NAcc to determine the specificity of our
brain-behavior correlations by including it as another covari-
ate using the partialcorr function in MATLAB.
Results
Our analyses indicated that functional coupling be-
tween VTA and right anterior hippocampus was signifi-
cantly greater in FEP versus HC (t(76) = 2.40, p, 0.05,
Bonferroni corrected, Cohen’s d=0.56; Fig. 2). Notably,
VTA-right anterior hippocampus functional coupling did
not differ across medicated and un-medicated FEP indi-
viduals. For the right hippocampus, there was no signifi-
cant difference between individuals on and off medication
(t(44) = 1.29, p. 0.20). For the right NAcc, there was no
significant difference between individuals on and off med-
ication (t(44) = 0.23, p. 0.81). A similar pattern to right
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anterior hippocampus-VTA was observed with left ante-
rior hippocampus-VTA functional coupling, although the
result was non-significant (t(76) = 1.47, p=0.15, Bonferroni
corrected, Cohen’s d=0.33; Fig. 2). As a control analysis,
we examined functional coupling of the VTA with the
PRC, a region also located in the MTL. There were no dif-
ferences in functional coupling between the VTA and PRC
across groups (right PRC: t(76) = 0.02 p=0.98, Cohen’s
d=0.00; left PRC: t(76) = 0.08 p=0.93, Cohen’s d=
0.02). Finally, we examined the NAcc, given its role in the
mesolimbic circuit, and found that functional coupling be-
tween VTA and right NAcc was significantly greater in HC
versus FEP (t(76) = 1.07, p, 0.05, Cohen’s d=0.53; Fig.
2). There was no difference between VTA and left NAcc
across groups (t(76) = 2.27 p=0.29, Cohen’s d=0.25).
This same pattern of results remained consistent for all
the above reported findings when including age and sex
as covariates of interest.
Because we observed group differences in VTA-right
hippocampus and VTA-right NAcc functional coupling,
we then assessed the relationship between these meas-
ures and Brief Psychiatric Rating Scale symptom severity
scores in the FEP group. We found a trend toward a posi-
tive correlation between VTA-right hippocampus func-
tional coupling and overall symptom severity (r(43) = 0.24,
p=0.10). This relationship was significant when controlling
for age, sex, and antipsychotic status (r(43) =0.30, p=0.05).
These results remained significant when including the VTA-
right NAcc into the model (r(39) = 0.39, p=0.01) to ensure
that findings were specific to the VTA hippocampal circuit.
There was no such relationship between VTA-right NAcc
(r(43) =0.14, p=0.36), and no such relationship when includ-
ing covariates of age, sex, and antipsychotic status (r(43) =
0.21, p=0.18). As well, there were no significant relation-
ships of these neural measures with subscales of positive or
negative symptoms (ps. 0.28).
Finally, we conducted a whole brain analysis to see
whether there were any significant differences in function-
al coupling with the VTA outside of ROIs. Notably, a
whole-brain analysis within each group showed strong
connectivity of the VTA with core regions within the
mesolimbic dopamine system, including dorsal stria-
tum, ventral striatum, hippocampus, amygdala, and
ventromedial prefrontal cortex (see https://osf.io/dtu5z/
for unthresholded z-maps). Whole-brain analysis did
not reveal any significant differences across FEP and
HC groups, when using whole brain correction. However,
at a more lenient, exploratory threshold (p, 0.001, cluster
extant. 15), the FEP group showed greater functional
coupling of the VTA with the right agranular frontal (BA6),
and less functional coupling of the VTA with the right inter-
mediate frontal area (BA8), compared with the CON group.
Figure 1. Lateral ROI diagram. Axis depicts analysis of ROI seed to each ROI target separately. ROI seed (in red box): VTA (red).
ROI targets (white background): NAcc (top right; pink, light green), PRC (middle; purple, light blue), and anterior hippocampus (HPC;
bottom; orange, dark blue). For visualization purposes remaining left and right HPC ROI depicted in dark green.
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These results should be interpreted with caution given the
liberal statistical thresholds.
Discussion
Results indicated that VTA-hippocampal rsfMRI func-
tional coupling is higher in individuals within their first epi-
sode of psychosis in comparison to normative controls.
We found that these psychosis-related increases in mes-
olimbic connectivity were specific to hippocampus/VTA
connectivity, as there were no differences in our other
MTL ROIs (i.e., PRC), a decrease in functional coupling
with the NAcc, and no robust differences in exploratory-
whole brain analyses. Further, individual differences in
VTA-hippocampus functional coupling within the FEP
group correlated to symptom severity as assessed by the
Brief Psychiatric Rating Scale.
Recent work has also shown disruptions in mesolimbic-
hippocampal circuits across different phases of psycho-
sis. In a sample with chronic psychosis, general psychosis
symptoms were correlated with hippocampal-VTA con-
nectivity, although, again, there were no significant group
differences in this circuit compared with a control group
(Nakamura et al., 2020). Here, we found group differences
in VTA-hippocampal connectivity in an FEP sample,
which highlights that functional coupling between these
regions may distinguish between different phases of psy-
chosis. Differences may have emerged in our study within
our FEP group because patients were either drug-naive or
only newly exposed to psychosis medication. Increased
VTA-hippocampal interactions may be more important in
early stages of the disorder, which reflects the lack of
group-level differences found in studies of chronic, lasting
psychosis treated for long durations with heavy medica-
tion. Thus, our data raises the possibility that after pro-
longed anti-psychotic treatment, individuals with chronic
psychosis may more closely resemble controls in regards
to mesolimbic circuit function. However, in chronic psy-
chosis, interactions in this circuit may only relate to posi-
tive symptoms which may not have been remediated
by anti-psychotic medication (Lieberman et al., 2001;
Fusar-Poli et al., 2015; Lieberman and First, 2018). Future
studies leveraging longitudinal cohorts will provide a bet-
ter understanding of interactions between mesolimbic-
Figure 2. Functional coupling. Axis depicts connectivity of seed to target during resting state fMRI and cohort differences in mean
activation. VTA seed to each lateral target: VTA to anterior hippocampus (HPC; top), VTA to PRC (bottom left), and VTA to NAcc
(bottom right). FEP cohort depicted in blue and HC cohort depicted in orange. Each dot represents a single participant. (*p, 0.05).
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hippocampal functional connectivity, psychosis duration,
and medication usage as well as the impact of negative
and positive symptoms.
Notably, recent work has demonstrated that mesolim-
bic-hippocampal interactions differentiate individuals at
CHR for psychosis from normative controls. CHR indi-
viduals showed reduced hippocampal activity during an
event-related novelty/salience task which drives hippo-
campal-midbrain-striatal response. The authors found
that CHR participants had significantly less activation
with stimulus novelty in the anterior right hippocampus,
but when using functional coupling as an approach to
understand the circuit, CHR subjects showed greater
VTA-hippocampal connectivity, along with reduced mid-
brain-striatum connectivity (Modinos et al., 2020). Thus,
our findings extend this literature to indicate that pat-
terns of connectivity not only persist into patient’s first
episode, but notably also generalize to task-free states.
These findings would then support a model by which
symptoms associated with mesolimbic-hippocampal in-
teractions, such as delusions and paranoia, may be
prominent at baseline and not just during states of nov-
elty. Of note, our study only reports correlation between
VTA-hippocampal coupling and symptom severity, and
future studies examining this circuit before and after
medication administration and the relationship with
symptoms will be necessary to support these implica-
tions in a broader context.
We also found that functional coupling between the
VTA-NAcc circuits was greater in HC versus FEP. Reduced
VTA-NAcc connectivity has also been shown during resting
state in psychosis-related populations with general severity
of symptoms (Nakamura et al., 2020), as well as during sali-
ence detection in CHR (Modinos et al., 2020). Connectivity
between the VTA and NAcc is known to be critical for ini-
tiating and maintaining goal-oriented behavior (Shohamy
and Adcock, 2010; Ballard et al., 2011; Berridge, 2012;
Wise and Robble, 2020) and alterations in NAcc engage-
ment has been associated with symptoms of anhedonia
(Lee et al., 2015; Zhang et al., 2016; Barkus and Badcock,
2019; Borsini et al., 2020), which are prominent in psycho-
sis (Kirkpatrick and Buchanan, 1990; Strauss and Gold,
2012). Together, these findings suggest that psychosis is
associated with increased functional coupling between the
VTA and hippocampus, and decreased functional coupling
between the VTA and striatum.
Critically, this dichotomy between reduced VTA con-
nectivity with the striatum and increased connectivity with
the hippocampus could begin to specify the complexity of
mesolimbic deficits in psychosis. Namely, psychosis
often presents with symptoms that seem to result from
hyperdopaminergic activation, such as delusions and par-
anoia, and symptoms that seem to result from hypodopa-
minergic activation, such as anhedonia. We propose that
divergent patterns across VTA subcircuits could help de-
termine paradoxical nature of symptoms, such that in-
creases in salience detection and delusions occur via
hippocampal neuromodulation, whereas decreased goal-
motivated behavior occur via striatal neuromodulation.
Our analysis of individual differences in symptoms did not
show this double-dissociation but rather a positive relation-
ship between hippocampal neuromodulation and overall
symptom severity (i.e., positive and negative symptoms).
However, engagement of VTA-NAcc circuits has been
shown to be sensitive to task context (Murty et al., 2018),
and brain-behavior relationships may only emerge in the
context of reward. Thus, future studies examining the rela-
tionship between VTA subcircuits and positive symptoms
during task states will be needed to test our hypotheses.
There are three main limitations to this study we have
identified here which can be address in future work. First,
while this study sought to describe aspects of psychosis
before long duration of heavy medication, many of our
FEP participants were not naive to medication. Our cur-
rent sample did not include enough drug naive individuals
to study them in isolation. Second, our only comparison
group was a HC group, which did not allow for examina-
tion across different neuropsychiatric disorders to deter-
mine whether functional alterations of mesolimbic circuits
are specific to psychosis. Future studies should investi-
gate how our findings are impacted in comparison to
other clinical groups, including early psychosis risk to
long-term psychosis patients. Third, as we only evaluated
the groups during rest, we cannot conclude any behav-
ioral differences between FEP and CON in this study.
The current study adds to growing literature character-
izing neural deficits in FEP. Our findings suggest that the
well-documented deficits in hippocampal function and
mesolimbic circuits in animal and human findings in psy-
chosis may actually reflect a dysfunction across the two
regions, resulting from the hippocampus over-stimulating
the VTA, and the VTA releasing excessive amounts of do-
pamine in the hippocampus. Although our results do not
directly indicate overstimulation of VTA or hippocampus
independently or directionally, our findings point toward a
correlation of VTA-hippocampus disruption in FEP during
rest. Critically, these alterations seem to be present, at
least, immediately after the onset of the disorder, and are
implicative of individual differences in symptom severity
of FEP. This characterization provides an important link be-
tween animal models of psychosis and human neuroimag-
ing, and serves as a foundation to understand how circuit-
level alterations in the mesolimbic system may contribute
to the heterogeneity of symptoms in psychosis.
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Modinos G, S imşek F, Azis M, Bossong M, Bonoldi I, Samson C,
Quinn B, Perez J, Broome MR, Zelaya F, Lythgoe DJ, Howes OD,
Stone JM, Grace AA, Allen P, McGuire P (2018) Prefrontal GABA
levels, hippocampal resting perfusion and the risk of psychosis.
Neuropsychopharmacology 43:2652–2659.
Modinos G, Allen P, Zugman A, Dima D, Azis M, Samson C, Bonoldi
I, Quinn B, Gifford GWG, Smart SE, Antoniades M, Bossong MG,
Broome MR, Perez J, Howes OD, Stone JM, Grace AA, McGuire P
(2020) Neural circuitry of novelty salience processing in psychosis
risk: association with clinical outcome. Schizophr Bull 46:670–679.
Murty VP, Alison Adcock R (2017) Distinct medial temporal lobe net-
work states as neural contexts for motivated memory formation.
In: The hippocampus from cells to systems: structure, connec-
tivity, and functional contributions to memory and flexible cog-
nition (Hannula DE, Duff MC, eds), pp 467–501. Cham: Springer
International Publishing.
Murty VP, Shermohammed M, Smith DV, Carter RM, Huettel SA,
Adcock RA (2014) Resting state networks distinguish human ven-
tral tegmental area from substantia nigra. Neuroimage 100:580–
589.
Murty VP, Tompary A, Adcock RA, Davachi L (2017) Selectivity in
postencoding connectivity with high-level visual cortex is associ-
ated with reward-motivated memory. J Neurosci 37:537–545.
Murty VP, Shah H, Montez D, Foran W, Calabro F, Luna B (2018)
Age-related trajectories of functional coupling between the VTA
and nucleus accumbens depend on motivational state. J Neurosci
38:7420–7427.
Nakamura Y, Okada N, Koshiyama D, Kamiya K, Abe O, Kunimatsu
A, Okanoya K, Kasai K, Koike S (2020) Differences in functional
connectivity networks related to the midbrain dopaminergic sys-
tem-related area in various psychiatric disorders. Schizophr Bull
46:1239–1248.
Research Article: New Research 7 of 8
March/April 2021, 8(2) ENEURO.0375-20.2021 eNeuro.org
Ritchey M, Wang S-F, Yonelinas AP, Ranganath C (2019)
Dissociable medial temporal pathways for encoding emotional
item and context information. Neuropsychologia 124:66–78.
Saykin AJ, Gur RC, Gur RE, Mozley PD, Mozley LH, Resnick SM,
Kester DB, Stafiniak P (1991) Neuropsychological function in
schizophrenia: selective impairment in memory and learning. Arch
Gen Psychiatry 48:618–624.
Schobel SA, Lewandowski NM, Corcoran CM, Moore H, Brown T,
Malaspina D, Small SA (2009) Differential targeting of the CA1 sub-
field of the hippocampal formation by schizophrenia and related
psychotic disorders. Arch Gen Psychiatry 66:938–946.
Shohamy D, Adcock RA (2010) Dopamine and adaptive memory.
Trends Cogn Sci 14:464–472.
Strauss GP, Gold JM (2012) A new perspective on anhedonia in
schizophrenia. Am J Psychiatry 169:364–373.
van Erp TGM, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD,
Andreassen OA, Agartz I, Westlye LT, Haukvik UK, Dale AM, Melle
I, Hartberg CB, Gruber O, Kraemer B, Zilles D, Donohoe G, Kelly S,
McDonald C, Morris DW, Cannon DM, et al. (2016) Subcortical
brain volume abnormalities in 2028 individuals with schizophrenia
and 2540 healthy controls via the ENIGMA consortium. Mol
Psychiatry 21:547–553.
Vargas T, Dean DJ, Osborne KJ, Gupta T, Ristanovic I, Ozturk S,
Turner J, van Erp TGM, Mittal VA (2018) Hippocampal subregions
across the psychosis spectrum. Schizophr Bull 44:1091–1099.
Wise RA, Robble MA (2020) Dopamine and addiction. Annu Rev
Psychol 71:79–106.
Zhang B, Lin P, Shi H, Öngür D, Auerbach RP, Wang X, Yao S, Wang
X (2016) Mapping anhedonia-specific dysfunction in a transdiag-
nostic approach: an ALE meta-analysis. Brain Imaging Behav
10:920–939.
Research Article: New Research 8 of 8
March/April 2021, 8(2) ENEURO.0375-20.2021 eNeuro.org
